Abstract:Objective Despite pituitary neuroendocrine tumor (PitNET) being extra‐axial tumors without direct damage to brain tissue, patients with PitNET exhibit neuropsychological impairments. However, it remains unclear whether there are neuropsychological differences between PitNET and intra‐axial tumors that directly destroy the brain parenchyma. This prospective study aims to clarify this distinction to inform decision‐making for intracranial tumors of diverse origins. Methods A total of 146 patients with PitNET, 74 patients with glioma representing intra‐axial tumors, and 52 age‐, sex‐, and education‐matched healthy controls were recruited. All patients received standard treatment and postoperative rehabilitation. Clinical data were meticulously collected, and neuropsychological tests were administered to all participants both before and 3 months after surgery. Results Both PitNET and glioma patients experience the dual burden of cognitive and affective deficits. However, the feature of these deficits differs substantially. In PitNET patients, the deficits are relatively mild and focal, whereas in glioma patients, they are severe and extensive. Specifically, PitNET patients exhibit deficits in memory, anxiety, and negative affect. In contrast, glioma patients display deficits in executive function, attention, anxiety, positive/negative affect, and empathy. Notably, except for persistent memory deficits, the majority of neuropsychological scores declines in PitNET patients are restorable and can reach improvement within a short period after standard surgical therapy and perioperative management. Conversely, glioma patients not only fail to show improvements but also demonstrate worsening in terms of general cognition and memory postoperatively. Interpretation As an extra‐axial tumor, PitNET may exhibit distinctive cognitive and affective functioning compared to intra‐axial tumors, highlighting the need for specific treatment approaches for PitNET patients.

The associations between risk factors and pituitary neuroendocrine tumors: A bidirectional Mendelian randomization study

Clinical Significance of the Preoperative Main Pancreatic Duct Dilation and Neutrophil-to-lymphocyte Ratio in Pancreatic Neuroendocrine Tumors (pnets) of the Head after Curative Resection

Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment

Single-Cell Sequencing Identifies Cellular Origins and Differentiation Markers for Molecular Classification and Recurrence Prediction of PitnNET

Immune landscape and progress in immunotherapy for pituitary neuroendocrine tumors

Intracranial seeding of pituitary neuroendocrine tumor: a case report

Causal Relationships between Gut Microbiotas, Blood Metabolites, and Neuroendocrine Tumors: A Mediated Mendelian Randomization Study

Single-cell Transcriptome and Genome Analyses of Pituitary Neuroendocrine Tumors.

"Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review"

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors

Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors

Analysis of clinical characteristics and prognosis of 63 cases of pancreatic neuroendo-crine tumor

Pituitary neuroendocrine tumor: A neuropsychological comparison with intra‐axial tumor

Digital Image Analysis Allows Objective Stratification of Patients with Silent PIT1-lineage Pituitary Neuroendocrine Tumors.

Elucidating the Causal Links Between Plasma and Cerebrospinal Fluid Metabolites and Pituitary Tumors: a Mendelian Randomization Analysis

Surgical Outcomes and Predictors of Visual Function Alterations after Transcranial Surgery for Large-to-Giant Pituitary Adenomas

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

Analysis of Risk Factors Affecting the Prognosis of Pancreatic Neuroendocrine Tumors

The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach

Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors

Analysis of gut microbiota-derived metabolites regulating pituitary neuroendocrine tumors through network pharmacology